REDUCED HUMAN IgG ANTI-ATGAM ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL1,2
THE RELATIVE EFFECTS OF FK506 AND CYCLOSPORINE ON SHORT- AND LONG-TERM KIDNEY GRAFT SURVIVAL1,2,3
SURVIVAL EXPERIENCE AMONG ELDERLY END-STAGE RENAL DISEASE PATIENTS
DONOR-SPECIFIC TRANSFUSIONS HAVE LONG-TERM BENEFICIAL EFFECTS FOR HUMAN RENAL ALLOGRAFTS1
DONOR RACE DOES NOT AFFECT CADAVER KIDNEY TRANSPLANT SURVIVAL—A SINGLE CENTER EXPERIENCE1
KIDNEY-PANCREAS TRANSPLANTATION
CHRONIC RENAL ALLOGRAFT REJECTION IN THE FIRST 6 MONTHS POSTTRANSPLANT1,2
IMPACT OF SERUM LIPIDS ON LONG-TERM GRAFT AND PATIENT SURVIVAL AFTER RENAL TRANSPLANTATION1
COMBINED SIMULTANEOUS KIDNEY/BONE MARROW TRANSPLANTATION1
OBESITY AS A RISK FACTOR AFTER COMBINED PANCREAS/KIDNEY TRANSPLANTATION1
EXPERIENCE WITH PROTOCOL BIOPSIES AFTER SOLITARY PANCREAS TRANSPLANTATION1
ABSORPTION CHARACTERISTICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN DE NOVO PEDIATRIC LIVER TRANSPLANT RECIPIENTS1,2
A RANDOMIZED PROSPECTIVE TRIAL OF STEROID WITHDRAWAL AFTER LIVER TRANSPLANTATION1,2
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN TRANSPLANTED HUMAN HEARTS1,2
THE UTILITY OF ANNUAL SURVEILLANCE BRONCHOSCOPY IN HEART-LUNG TRANSPLANT RECIPIENTS1,2
PSYCHOSOCIAL EVALUATION AND PREDICTION OF COMPLIANCE PROBLEMS AND MORBIDITY AFTER HEART TRANSPLANTATION1
VENTRICULAR REMODELING FOLLOWING INFANT-PEDIATRIC CARDIAC TRANSPLANTATION
PROPHYLACTIC GANCICLOVIR TREATMENT REDUCES FUNGAL AS WELL AS CYTOMEGALOVIRUS INFECTIONS AFTER HEART TRANSPLANTATION1,2
THE RELATIONSHIP OF GRANZYME A AND PERFORIN EXPRESSION TO CARDIAC ALLOGRAFT REJECTION AND DYSFUNCTION1
SARCOMAS IN ORGAN ALLOGRAFT RECIPIENTS1,2
THE RISKS, BENEFITS, AND COSTS OF EXPANDING DONOR CRITERIA
GENETIC CONTROL OF THE HUMORAL IMMUNE RESPONSE TO XENOGRAFTS
GENETIC CONTROL OF THE HUMORAL IMMUNE RESPONSE TO XENOGRAFTS
PREVENTION OF GRAFT-VERSUS-HOST DISEASE AND THE INDUCTION OF TRANSPLANT TOLERANCE BY LOW-DOSE UV-B IRRADIATION OF BM CELLS COMBINED WITH CYCLOSPORINE IMMUNOSUPPRESSION1
DOWNREGULATION OF INTRAGRAFT IFN-γ EXPRESSION CORRELATES WITH INCREASED IgG1 ALLOANTIBODY RESPONSE FOLLOWING INTRATHYMIC IMMUNOMODULATION OF SENSITIZED RAT RECIPIENTS1,2
BINDING OF ACTIVATED PROTEIN C TO A SPECIFIC RECEPTOR ON HUMAN MONONUCLEAR PHAGOCYTES INHIBITS INTRACELLULAR CALCIUM SIGNALING AND MONOCYTE-DEPENDENT PROLIFERATIVE RESPONSES1,2
EXPRESSION OF CYTOKINES AND IMMUNE MEDIATORS DURING CHRONIC LIVER ALLOGRAFT REJECTION1
BONE MARROW-DERIVED DENDRITIC CELL PROGENITORS (NLDC 145+, MHC CLASS II+, B7-1dim, B7-2−) INDUCE ALLOANTIGEN-SPECIFIC HYPORESPONSIVENESS IN MURINE T LYMPHOCYTES1,2
ORGAN-SPECIFIC PATTERNS OF DONOR ANTIGEN-SPECIFIC HYPOREACTIVITY AND PERIPHERAL BLOOD ALLOGENEIC MICROCHIMERISM IN LUNG, KIDNEY, AND LIVER TRANSPLANT RECIPIENTS1
IDENTIFICATION OF DONOR-DERIVED DENDRITIC CELL PROGENITORS IN BONE MARROW OF SPONTANEOUSLY TOLERANT LIVER ALLOGRAFT RECIPIENTS1,2
ACUTE RENAL INJURY IN THE INTERFERON-γ GENE KNOCKOUT MOUSE
LEW-TO-F344 CAROTID ARTERY ALLOGRAFTS
MUCOSAL PERFUSION AND REACTIVITY OF THE RAT SMALL INTESTINAL ALLOGRAFT
PREVENTION OF FUNCTIONAL, STRUCTURAL, AND MOLECULAR CHANGES OF CHRONIC REJECTION OF RAT RENAL ALLOGRAFTS BY A SPECIFIC MACROPHAGE INHIBITOR1,2
INHIBITORY EFFECT OF PLASMA FKBP12 ON IMMUNOSUPPRESSIVE ACTIVITY OF FK5061,2
DETECTION OF HLA IgG ANTIBODIES BY TWO ENZYME-LINKED IMMUNOASSAYS, SOLUBILIZED HLA CLASS I AND PRA-STAT
SOLUBLE HLA ANTIGENS AND ELISA—A NEW TECHNOLOGY FOR CROSSMATCH TESTING1
EVALUATION OF HLA ANTIBODIES WITH THE PRA-STAT TEST
ASSESSMENT OF METHYLPREDNISOLONE PHARMACOKINETICS AND CORTISOL RESPONSE DURING THE EARLY AND CHRONIC POSTRENAL TRANSPLANT PERIODS1,2